top | item 45693339

(no title)

ZordonShumway | 4 months ago

From what I’ve seen, studies haven’t done a good job of actually testing for testing lifetime expectancy.

https://pmc.ncbi.nlm.nih.gov/articles/PMC11047044/

“In conclusion, the statement that cancer screenings do not save lives cannot be properly drawn from the Bretthauer's et al. meta-analysis because lifetime gains are likely underestimated and based on uncertain all-cause mortality estimates.

Lifetime gains estimated for the screened group from all-cause mortality reduction is a misleading measure and should be avoided because it implies a benefit for all persons in the screening group, including those not affected by the target cancer.”

https://bmchealthservres.biomedcentral.com/articles/10.1186/...

“Although gaps persist between the full potential benefit and benefits considering adherence, existing cancer screening technologies have offered significant value to the US population. Technologies and policy interventions that can improve adherence and/or expand the number of cancer types tested will provide significantly more value and save significantly more patient lives.”

discuss

order

No comments yet.